Verona Pharma's market cap is currently $5.25B. The company's EPS TTM is $-1.938; its P/E ratio is ―; Verona Pharma is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.03. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 458.00K	$ 40.00M	$ 0.00	$ 2.35K
Gross Profit	$ -679.62K	$ 112.00K	$ 40.00M	$ -627.85K	$ -509.76K
Operating Income	$ -67.83M	$ -66.12M	$ -73.31M	$ -74.28M	-
EBITDA	$ -52.47M	$ -67.29M	$ -42.19M	$ -47.81M	$ -32.17M
Net Income	$ -54.37M	$ -68.70M	$ -55.57M	$ -65.15M	-
Balance Sheet
Cash & Short-Term Investments	$ 271.77M	$ 227.83M	$ 148.38M	$ 187.99M	$ 40.33M
Total Assets	$ 308.12M	$ 259.47M	$ 186.59M	$ 204.21M	$ 59.18M
Total Debt	$ 51.33M	$ 10.65M	$ 5.81M	$ 5.95M	$ 1.25M
Net Debt	$ -220.44M	$ -217.18M	$ -142.57M	$ -182.04M	$ -28.82M
Total Liabilities	$ 58.84M	$ 29.00M	$ 38.58M	$ 19.35M	$ 14.78M
Stockholders' Equity	$ 249.28M	$ 230.47M	$ 148.00M	$ 184.85M	$ 44.40M
Cash Flow
Free Cash Flow	$ -50.22M	$ -59.89M	$ -33.27M	$ -45.16M	-
Operating Cash Flow	$ -50.22M	$ -59.86M	$ -33.25M	$ -45.08M	-
Investing Cash Flow	$ 0.00	$ -29.00K	$ -12.00K	$ 9.71M	$ 49.56M
Financing Cash Flow	$ 92.87M	$ 140.82M	$ -6.12M	$ 192.34M	-

Currency in USD

Verona Pharma Earnings and Revenue History

Income Statement >

Verona Pharma Debt to Assets

Balance Sheet >

Verona Pharma Cash Flow

Cash Flow >

Verona Pharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing